Valuation GSK plc

Equities

Market Closed - London S.E. Other stock markets 01:35:14 15/04/26 am AEST			5-day change	1st Jan Change
2,190.00 ^GBX	+0.92%		+2.15%	+20.03%

14/04	Betting on Restraint
14/04	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	80,458	58,381	59,112	54,944	73,201	87,488	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	19.52%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	99,613	96,854	95,080
Change	-	-24.65%	-1.89%	-8.24%	28.83%	13.64%	-2.77%	-1.83%
P/E ratio	18.6x	3.93x	11.9x	21.3x	12.9x	13.9x	13x	12.1x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.54x	3.83x	3.39x
PEG	-	0x	-0.2x	-0.4x	0x	1.2x	1.9x	1.73x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.58x	2.46x	2.39x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.93x	2.72x	2.6x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.5x	7.79x	7.47x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.68x	8.73x	8.13x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	15.8x	15.3x	13.4x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.35%	6.55%	7.47%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6987	0.7589	0.7606
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.19%	3.47%	3.47%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.581	1.689	1.807
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	44.2%	44.9%	42.1%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,975	35,579	36,601
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,715	12,429	12,722
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,286	11,099	11,691
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,338	6,749	7,237
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	12,125	9,366	7,593
Reference price ²	20.08	14.38	14.50	13.46	18.24	21.90	21.90	21.90
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	3,994,878	-	-
Announcement Date	9/2/22	1/2/23	31/1/24	5/2/25	4/2/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GSK PLC	13.8x	2.9x	8.41x	3.22%	117B
ELI LILLY AND COMPANY	27.39x	10.36x	20.75x	0.73%	832B
JOHNSON & JOHNSON	25.22x	5.87x	15.95x	2.22%	573B
ABBVIE INC.	23.23x	6.22x	12.63x	3.36%	365B
ASTRAZENECA PLC	25.43x	5.25x	14.83x	1.65%	313B
MERCK & CO., INC.	28.43x	4.94x	15.35x	2.81%	297B
NOVARTIS AG	21.18x	5.7x	13.8x	2.88%	292B
AMGEN INC.	23.4x	6.05x	10.77x	2.87%	189B
GILEAD SCIENCES, INC.	19.14x	5.87x	10.78x	2.34%	173B
Average	23.03x	5.91x	13.70x	2.45%	349.98B
Weighted average by Cap.	24.65x	6.83x	15.59x	2.1%